
Dartmet VG 1mg/500mg/0.2mg Tablet
Marketer
Addii Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Dartmet VG 1mg/500mg/0.2mg Tablet
Diabetol Trio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus, facilitating blood glucose regulation. Diabetol Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with well-controlled blood sugar. Discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Prompt recognition and treatment are essential. Maintaining regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Dartmet VG 1mg/500mg/0.2mg Tablet
No text provided to rephrase.
Uses of Dartmet VG 1mg/500mg/0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Dartmet VG 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dartmet VG 1mg/500mg/0.2mg tablets on an empty stomach.
Common Side effects of Dartmet VG 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Dartmet VG 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dartmet VG 1mg/500mg/0.2mg tablets on an empty stomach.
How Dartmet VG 1mg/500mg/0.2mg Tablet works:
Each Dartmet VG tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Dartmet VG 1mg/500mg/0.2mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dartmet VG 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dartmet VG 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dartmet VG 1mg/500mg/0.2mg Tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Dartmet VG 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dosage; the tablet is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Dartmet VG 1mg/500mg/0.2mg Tablet :
Should you forget a Dartmet VG 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dartmet VG 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
